Bloomberg News

Collplant Approved for Diabetes Injuries Human Clinical Study

October 10, 2011

Oct. 10 (Bloomberg) -- Collplant Holdings Ltd. said its unit received necessary permits to undertake together Israeli health provider Maccabi Health Services a first human clinical study for the treatment of chronic diabetic injuries with its Vergenix bandages, the biotechnology company said in a statement to the Tel Aviv Stock Exchange today.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Calev Ben-David at cbendavid@bloomberg.net


American Apparel's Future
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus